Ana Sayfa | Dergi Hakkında | Yayın Kurulu | Bilimsel Danışma Kurulu | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | İletişim  
2017, Cilt 31, Sayı 3, Sayfa(lar) 145-155   
Kadir SOYKÖK1, Sulhattin ARSLAN1, Yeltekin DEMİREL1
1Cumhuriyet Ünv Tıp Fak, Aile Hekimliği, Sivas, Türkiye
2Cumhuriyet Ünv Tıp Fak, Göğüs Hastalıkları, Sivas, Türkiye
Keywords: COPD, Comorbidity, Coronary Artery Disease, Congestive Heart Failure

Aim: Comorbidities are common in COPD and they may have important effects on prognosis. The most frequent comorbidities in COPD including; musculoskletal abnormalities, hypertension, diabetes, heart failure, cancers and coronary artery, pulmonary vascular and cerebrovascular diseases. The aim of this study is to detect the most common comorbidities in COPD. To investigate the association of comorbid incidence with gender, inflammation, and severity of COPD

Material and Methods: Our study has been conducted on 179 patients diagnosed with COPD, Comorbidities of patients were recorded through direct conversation with them and researching their folder retrospectively. Certain parameters of patients were recorded such as arterial blood gas (ABG), C-reactive protein (CRP), hemoglobin (Hgb), hematocrit (Hct) and mild cellular volume (MCV) through analyzing of their folders retrospectively.

Results: Mean age was 64.51±11.04 and 64,8% of patients had at least one comorbidity. The most common comorbidities included hypertension (HT; 60,9%), diabetes (DM; 27,4%), coronary artery disease (CAD; 33%), congestive heart failure (CHF; 20, 1%), cerebrovascular disease (CVD; 8,4%), depression (19,6%), anemia (13,4%), peptic ulcer (11,2%), gastroesophageal reflux (GER; 15,6%), lung cancer (3,4%), osteoporosis (15,6%), obstructive sleep apnea hypopnea syndrome (8,9%), chronic renal failure (4,5%), peripheral vessel disease (PVD; 9,5%) and pulmonary hypertension (PHT: 4.5%).

Conclusion: As a result, according to our study hypertension, coronary artery disease and diabetes have been considered as the most common comorbidities.